Outset Medical posts 5% revenue growth, adds board member
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Outset Medical Reports Unaudited Fourth Quarter and 2025 Results
January 12, 2026 8:30 AM ESTAppoints Medical Technology Veteran Karen N. Prange to Board of Directors
SAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported unaudited revenue for the fourth quarter and fiscal year ended December 31, 2025, and named Karen N. Prange to its board of directors.
Unaudited Fourth Quarter and 2025 Results
Revenue in the fourth quarter totaled approximately $28.9 million, bringing revenue for 2025 to... More